YaleABNLab retweeted
Had such a great time at my first @CPDDorg ✨
This chapter is over, but the journey continues. Excited to keep exploring what drives cannabis use and how these motivations shape people’s experiences. @YalePsych @YaleABNLab @anahitabassir #CPDD2026#cannabisuse
YaleABNLab retweeted
Why people with psychosis use cannabis more than general population? My amazing postdoc, @YaldaFarahmand, presented our study trying to answer this question at #CPDD2026.
@YaleABNLab – at West Haven, CT
I’m honored to present our study on cannabis motivations at the @CPDDorg this year! I’d be excited to meet everyone at the poster sessions tomorrow! @YalePsych @YaleABNLab @anahitabassir
#cannabismotivation#YalePsychiatry#CPDD2026
YaleABNLab retweeted
MEAI is a non-hallucinergic psychedelic with chemical structure similar to MDMA.
In this review from our lab, we discussed the potential Therapeutic use if MEAI in the treatment of alcohol use disorder (AUD).
#psychedelics
#MDMA
#MEAI
@YaleABNLab
@YalePsych – at West Haven, CT
YaleABNLab retweeted
We will discuss findings and lessons learned from our ongoing first-in-human clinical trial of MEAI in healthy participants and individuals with alcohol use disorder.
@YaleABNLab
@YalePsych – at West Haven, CT
YaleABNLab retweeted
Excited to receive #ACNP senior researcher travel award!
Looking forward to a wonderful meeting #acnp2026 in #Bahamas (Jan 2026)!
@YalePsych
@YaleABNLab
@ACNPorg
YaleABNLab retweeted
Dr. Anahita Bassir Nia focuses on translational research on the neurobiology of stress-related disorders and addiction, with a main focus on cannabinoids and psychedelics 🍄💊 / @anahitabassir











